HIV and AIDS Trial, Recruiting (NCT00789009)

HIV and AIDS Trial, Recruiting NCT00789009 Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Condition: HIV and AIDS

Printed from Voxsanity (voxsanity.com.au) — NCT00789009 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hiv Aids

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with HIV, confirmed by blood tests, or have lab results or symptoms that suggest you may possibly have HIV (confirm with trial site)
You are 18 years old or older
You are able to understand what the study involves and are willing to sign a consent form agreeing to take part
If you are in Group I, you must already have a regular doctor outside of NIH who looks after your general (non-HIV) health
If you are in Group II, you must have a doctor or clinic that will continue to manage both your HIV and general healthcare
If you are in Group I, you must live within roughly 100 miles of the NIH campus in Bethesda, Washington DC

Who may not be able to join:

You are currently struggling with drug or alcohol use or dependence, or you have another condition that the study team feels could make it difficult for you to follow the study's requirements
You are not willing to allow the study team to collect and store samples (such as blood) for research purposes

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 9 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Michael C Sneller, M.D., National Institute of Allergy and Infectious Diseases (NIAID)

Phone: (301) 761-7395

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT00789009

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Phase: Not Applicable

Status: Recruiting

Condition: HIV and AIDS

Trial contact: (301) 761-7395

More information: https://clinicaltrials.gov/study/NCT00789009

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with HIV, confirmed by blood tests, or have lab results or symptoms that suggest you may possibly have HIV (confirm with trial site)
You are 18 years old or older
You are able to understand what the study involves and are willing to sign a consent form agreeing to take part
If you are in Group I, you must already have a regular doctor outside of NIH who looks after your general (non-HIV) health
If you are in Group II, you must have a doctor or clinic that will continue to manage both your HIV and general healthcare
If you are in Group I, you must live within roughly 100 miles of the NIH campus in Bethesda, Washington DC

Who may not be able to join:

You are currently struggling with drug or alcohol use or dependence, or you have another condition that the study team feels could make it difficult for you to follow the study's requirements
You are not willing to allow the study team to collect and store samples (such as blood) for research purposes

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 9 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Registry

ClinicalTrials.gov

Start date

20 November 2008

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

This study will provide a clinically well-characterized cohort of HIV infected individuals to support ongoing clinical and laboratory based NIAID intramural research programs described above.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov